TLR4 and COVID-19: Taken together, these data suggest that the interaction of rSP with TLR2 and TLR4 on NK cells may have a strong impact on the immunopathology of COVID-19 and provides a clue that such receptors and/or their intracellular pathways could represent potential therapeutic targets.